Format

Send to

Choose Destination
Leukemia. 2017 May;31(5):1217-1220. doi: 10.1038/leu.2017.22. Epub 2017 Jan 18.

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia.

Author information

1
Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
2
NCT Trial Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
3
Department of Internal Medicine III, University Hospital of Bonn, Bonn, Germany.
4
Department of Internal Medicine II, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
5
Department of Oncology and Hematology, Klinikum Oldenburg, Oldenburg, Germany.
6
Department of Internal Medicine I, University Hospital of Saarland, Homburg, Germany.
7
Department of Internal Medicine III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
8
Department of Hematology/Oncology, University-hospital Giessen, Giessen, Germany.
9
Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
10
Department of Internal Medicine III, Technical University of Munich, Munich, Germany.
11
Department of Internal Medicine V, University Hospital Innsbruck, Innsbruck, Austria.
12
Department of Medicine III, Johannes Gutenberg-University Mainz, Mainz, Germany.
13
Department of Hematology and Oncology, University Hospital of Freiburg, Freiburg, Germany.
14
Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany.
15
Department of Hematology/Oncology, Asklepios Klinik Altona, Hamburg, Germany.
16
Department of Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany.
17
Department of Hematology/Oncology, Hanuschkrankenhaus, Wien, Austria.
18
Department of Hematology Oncology, Kliniken Essen-Süd, Essen, Germany.
19
Department of Internal Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
20
Department of Hematology/Oncology, Caritas-Krankenhaus, Lebach, Germany.
21
Department of Hematology/Oncology, Krankenhaus der Barmherzigen Brüder, Trier, Germany.
22
Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany.
23
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
PMID:
28096533
PMCID:
PMC5420792
DOI:
10.1038/leu.2017.22
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center